FDA Inspection
Element Materials Technology Oakland-ConcordElement Materials Technology Oakland-Concord – FDA Inspection, Dec 21, 2018
Record Details
This FDA Inspection record concerns Element Materials Technology Oakland-Concord, with an inspection on December 21, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 21, 2018
- Product Type
- Drugs
View Company Profile
ID · fcc0f6e0-f744-4452-a5cb-fec6a92ef724
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1076021
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Element Materials Technology Oakland-Concord
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2026 | OAI | San Francisco District Office | Drug Quality Assurance |
| March 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 16, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Element Materials Technology Oakland-Concord
- FDA Inspection 1300524 - 2026-01-30
- FDA Inspection 1165719 - 2022-03-22
- FDA Inspection 889833 - 2014-07-08
- FDA Inspection 589823 - 2009-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.